Cargando…
(577) Parvovirus B19 Myocarditis in a Covid19 MIS-C Syndrome: Cause or Causality?
INTRODUCTION: Myocarditis has been recognized as one of major complication during COVID 19 infections and vaccination. Few data are currently available on viral detection during myocardial damage in pediatric population. CASE REPORT: A previously healthy 13 year old boy presented with abdominal pain...
Autores principales: | Bellettini, E., Mencarelli, E., Rebonato, M., Francalanci, P., Cantarutti, N., Alfieri, S., Galletti, L., Kirk, R., Amodeo, A., Adorisio, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068074/ http://dx.doi.org/10.1016/j.healun.2023.02.592 |
Ejemplares similares
-
Heart rate reduction as a marker to optimize carvedilol treatment and enhance myocardial recovery in pediatric dilated cardiomyopathy
por: Adorisio, Rachele, et al.
Publicado: (2022) -
Parvovirus B19 Myocarditis of Fulminant Evolution
por: Spartalis, Michael, et al.
Publicado: (2017) -
A Case of Fetal Parvovirus B19 Myocarditis That Caused Terminal Heart Failure
por: Hichijo, Atsuko, et al.
Publicado: (2014) -
Acute Heart Failure Caused by Parvovirus B-19 Myocarditis Treated with Human Immunoglobulin
por: Alberti, Luca, et al.
Publicado: (2012) -
Fulminant myocarditis parvovirus B19 related in a young woman
por: Pesce, Rita, et al.
Publicado: (2021)